Like I said before, We have more than enough chicken Noodle soup to cover any ebola issues in the US.

Plus to contract it in the first place you literally have to have an infected person bust a nut all over your face.

So you're OK with them leaving those things laying around as long as there's only a small chance of an outbreak?

There are safety controls in place to prevent outbreaks. A minor issue inside a controlled facility has nothing to do with the broader environment.

Those incidents happened because safety protocols were not followed. And the anthrax incident involved unsafe shipping of active samples between labs. It wasn't contained to one controlled facility.

Now there two people with Ebola

http://www.nytimes.com/2014/08/06/us...anta.html?_r=0

There are different protocols for the different biosafety levels involved. There are measures in place to ensure that mistakes at a lower BSL cannot happen at a higher BSL. Those protocols have worked for many decades.

Man, looking at the pic in the article, there is no way that lady could ever date Donald Sterling. He'd have a stroke if that was his gf in that picture.

Nuke the site from orbit. It's the only way to be sure.

<iframe width="560" height="315" src="//www.youtube.com/embed/aCbfMkh940Q" frameborder="0" allowfullscreen></iframe>

Hope for the 2 Americans infected with Ebola. Perhaps this will help some understand why we didn't simply abandon these Americans and let them die because we were scared.

Bio-high-tech treatment for Ebola may have saved two US citizens


CNN reported Monday that the two US citizens who were flown back to the states after contracting the Ebola virus were given an extremely experimental treatment, one that's still undergoing animal testing. While the treatment involves antibodies, it's not a vaccine, and it can work effectively even after an infection has started. The process that produced it is a testament to the impressive capabilities developed in the field of biotechnology.

The Ebola virus, known for its horrific symptoms and high fatality rate, currently has no established treatment. The health care workers who are fighting the disease—and are thus at high risk for becoming infected themselves—can do little more than put themselves in isolation and try to compensate for the damage the virus causes. That situation was apparently the case for two Americans who contracted the virus while working in Liberia.

In this case, however, both people were apparently given an experimental treatment developed in part by a company called Mapp Biopharmaceutical.

[...]

Mapp has been pursing that testing, starting in mice and working its way up to primates. The company has also been shifting steadily later into the infection process. Its first tests showed that the treatment could be used prophylactically, given to monkeys prior to infection. In the researchers' most recent published work, from about a year ago, they used it on macaques that were already developing fevers as a result of the infection. Nearly half of the animals survived, while the infection was completely fatal in the control group.

Notably, that paper had members of the US Army Medical Research Institute of Infectious Diseases among its authors, suggesting that further development had a party with deep pockets willing to back the research through human trials. But it's not clear whether those trials had even started when, according to CNN, vials of the treatment were rushed to Liberia. And there's no way of telling how much, if at all, the antibodies helped the two people they were given to. We'll have to wait for larger clinical trials.

If the process described above—with infinite antibodies, cloning, mixing genes from different species, and mass production in plant cells—sounds like science fiction, it shouldn't. Every single one of those procedures is well established and has probably been used by a hundred biotech startups by now. Biotech doesn't tend to get the same attention as the work done by the people who make our processors and batteries, but it's some of the most amazing technology on the planet.

Yea, because not bringing them to the middle of the U.S. is the same as abandoning them.

Idiot.

Yes. Yes it is.

If you think that the care they'd receive in the MIDDLE OF BUTT**** AFRICA is going to be anywhere near what they'll get here, I can't help you.

Wow.

If they took your advice, the patients would be dying in Africa right now instead of having hope of survival here at home in their own country. Instead, they might have found a way to save 2 American lives and produce a treatment for Ebola. Luckily there are some doctors out there who are more brave than some people here.

I thought that the two Americans were given the experimental serum while they were still in Africa, though.

No, No it's not.

Didn't say they had to remain in the middle of Africa. But there had to be a better option than flying them to the middle of the U.S.

middle of Africa or the middle of America ... yep, the only 2 options. :rolleyes:


Take the doctors to them.

There has to be a more remote facility than gawd dam center of the U.S.

Even Hawaii would be better than the middle of America where an outbreak would be hard as hell to control. At least on Hawaii it's surrounded by water and semi contained. Had to be a more isolated option.